STOCK WARRANTS |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK WARRANTS |
NOTE 8 – STOCK WARRANTS
At June 30, 2021, warrant shares outstanding were as follows:
At December 31, 2020, the Company had outstanding warrants exercisable into shares of the Company’s common stock, of which warrants were issued in connection with a July 2020 private placement of the Company’s common stock, and the remaining 120,000 warrants were issued to underwriters in a December 2016 offering.
During the six months ended June 30, 2021, warrants to purchase shares of common stock were exercised at $3.13 exercise price per share or total net proceeds to the Company of $707 upon exercise. Also during the six months ended June 30, 2021, warrants exercisable into 120,000 shares of the Company’s common stock were exercised under a cashless exercise option into shares of the Company’s common stock.
The intrinsic value of the outstanding and exercisable warrants at June 30, 2021 was .
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||